Key result
Propofol-remifentanil fails to reduce perioperative myocardial ischemia over sevoflurane in TURP.
Why the study?
The comparative effects of propofol-remifentanil-based intravenous anesthesia and sevoflurane-based balanced anesthesia on ST-segment-defined myocardial ischemia and hemodynamic stability in elderly ASA II-III patients with cardiovascular comorbidities undergoing monopolar TURP warranted evaluation.
Does propofol–remifentanil–based intravenous anesthesia reduce the incidence of perioperative ST-segment–defined myocardial ischemia compared with sevoflurane-based balanced anesthesia in elderly ASA II–III patients with cardiovascular comorbidities undergoing monopolar TURP?
RCT (n=66)
Single-blind (anesthesiologist unblinded; patients, surgeons, postoperative clinical assessors, data analysts, and ECG-interpreting cardiologist blinded)
1:1 computer-generated allocation with sealed envelopes
No
Does propofol–remifentanil–based intravenous anesthesia reduce the incidence of perioperative ST-segment–defined myocardial ischemia compared with sevoflurane-based balanced anesthesia in elderly ASA II–III patients with cardiovascular comorbidities undergoing monopolar TURP?
In elderly patients with cardiovascular comorbidities undergoing monopolar TURP, propofol–remifentanil–based intravenous anesthesia provided better hemodynamic stability and transiently lower early postoperative ST-segment ischemia at 15 minutes compared to sevoflurane-based balanced anesthesia, without reducing overall perioperative ischemic burden or CK-MB-defined myocardial injury.
Answers are grounded in this paper and cite their sources.
Propofol-remifentanil offers no ischemia-prevention advantage over sevoflurane in high-risk TURP; leaves open whether transient early differences warrant agent-specific selection.
Objective: This historical cohort, originally collected as a prospective, randomized study was re-analyzed to compare propofol–remifentanil–based intravenous anesthesia (P‑RIA) and sevoflurane‑based balanced anesthesia (BA) regarding ST‑segment–defined myocardial ischemia and hemodynamic stability in elderly ASA II–III patients with cardiovascular comorbidities undergoing monopolar transurethral resection of the prostate (TURP). As troponin measurements were unavailable, myocardial injury after non‑cardiac surgery (MINS) was considered only as a conceptual framework rather than a predefined endpoint.Methods: Sixty‑six patients scheduled for elective monopolar TURP (n = 33 per group) were randomized in a single‑center, outcome‑assessor‑blinded design to receive P‑RIA or BA. Continuous ST‑segment monitoring (leads DII, V5, aVL) was performed from 15 minutes before induction to 15 minutes postoperatively. ECGs were read by a blinded cardiologist, and hemodynamics, electrolytes, and CK‑MB/CK were recorded serially.Results: Baseline demographic and surgical characteristics, as well as overall ischemia incidence and duration, were similar between groups. Blood pressure and heart rate were lower and more stable with P‑RIA. At 15 minutes postoperatively, ischemia was less frequent in the P‑RIA group than in the BA group (15.2% vs 36.4%; p = 0.045), an exploratory finding. CK‑MB levels, CK‑MB/CK ratios, electrolyte values, and postoperative complications did not differ significantly.Conclusion: In this elderly, comorbid TURP cohort, P‑RIA was associated with a more stable hemodynamic profile and a transiently lower early postoperative ischemia rate, without reducing total perioperative ischemic burden or CK‑MB–based myocardial injury. The data are hypothesis‑generating and require confirmation in larger troponin‑based MINS studies.
No takes yet. Share an insight, caveat, or question.
Mutlu et al. (2026) conducted an RCT in Benign prostatic obstruction undergoing elective monopolar transurethral resection of the prostate (TURP) with cardiovascular comorbidities (n=66). Propofol-remifentanil-based intravenous anesthesia (P-RIA) vs. Sevoflurane-based balanced anesthesia (BA; induction with remifentanil 0.5-1 µg/kg + etomidate 0.15-0.25 mg/kg; maintenance with 1-3% sevoflurane in 66% N2O/33% O2) was evaluated on Overall incidence of perioperative ST-segment-defined myocardial ischemia (ARR 9.1%, p=0.457). Propofol-remifentanil intravenous anesthesia did not significantly reduce overall perioperative ST-segment myocardial ischemia vs sevoflurane balanced anesthesia (39.4% vs 48.5%, p=0.457) in TURP.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: